{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:38:38Z","timestamp":1770273518291,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u00c5\u0084ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/ZDS\/007717"],"award-info":[{"award-number":["K\/ZDS\/007717"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.thromres.2020.05.037","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T22:01:25Z","timestamp":1590616885000},"page":"116-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Acceptance of a potential major bleeding among patients with venous thromboembolism on long-term oral anticoagulation: the knowledge of the disease and therapy matters"],"prefix":"10.1016","volume":"193","author":[{"given":"Ma\u0142gorzata","family":"Konieczy\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Kupis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Bijak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof Piotr","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2020.05.037_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","article-title":"The epidemiology of venous thromboembolism","volume":"41","author":"Heit","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2020.05.037_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz726","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","author":"Konstantinides","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2020.05.037_bb0015","doi-asserted-by":"crossref","first-page":"l4363","DOI":"10.1136\/bmj.l4363","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ."},{"key":"10.1016\/j.thromres.2020.05.037_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2017.02.016","article-title":"Bleeding risk in patients with unprovoked venous thromboembolism: a critical appraisal of clinical prediction scores","volume":"152","author":"Van Es","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.05.037_bb0025","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/jth.13524","article-title":"The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study","volume":"14","author":"Kyrle","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"150","key":"10.1016\/j.thromres.2020.05.037_bb0030","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0094-2018","article-title":"Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review","volume":"27","author":"van der Wall","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.thromres.2020.05.037_bb0035","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-147-11-200712040-00007","article-title":"The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism","volume":"147","author":"Douketis","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2020.05.037_bb0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/rth2.12214","article-title":"Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism","volume":"3","author":"Klok","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.05.037_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1183\/09031936.00040714","article-title":"Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review","volume":"45","author":"Klok","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.thromres.2020.05.037_bb0050","first-page":"672","article-title":"All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillation","volume":"17","author":"Ghate","year":"2011","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.thromres.2020.05.037_bb0055","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","article-title":"Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism","volume":"152","author":"Carrier","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2020.05.037_bb0060","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood-2014-07-590323","article-title":"The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis","volume":"124","author":"Chai-Adisaksopha","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.05.037_bb0065","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"Van Es","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.05.037_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007901","article-title":"Risk stratification for bleeding complications in patients with venous thromboembolism: application of the HAS-BLED bleeding score during the first6 months of anticoagulant treatment","volume":"7","author":"Brown","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2020.05.037_bb0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.thromres.2020.05.037_bb0080","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1182\/bloodadvances.2018020230","article-title":"Who should get long-term anticoagulant therapy for venous thromboembolism and with what?","volume":"2","author":"Rodger","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2020.05.037_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ahj.2014.04.007","article-title":"Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3\u20134, 2012","volume":"168","author":"Hess","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2020.05.037_bb0090","first-page":"465","article-title":"Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation","volume":"111","author":"Lahaye","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.05.037_bb0095","first-page":"28","article-title":"Knowledge gaps in patients with venous thromboembolism: usefulness of a new questionnaire","volume":"129","author":"Konieczy\u0144ska","year":"2019","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2020.05.037_bb0100","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/jth.13031","article-title":"Global public awareness of venous thromboembolism","volume":"13","author":"Wendelboe","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.05.037_bb0105","article-title":"Bleeding tolerance among patients with atrial fibrillation on oral anticoagulation","author":"Rusin","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.thromres.2020.05.037_bb0110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2017-07-798306","article-title":"Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study","volume":"131","author":"Cieslik","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2020.05.037_bb0115","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.thromres.2020.05.037_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/17474086.2019.1583555","article-title":"Thrombophilia, risk factors and prevention","volume":"12","author":"Campello","year":"2019","journal-title":"Expert. Rev. Hematol."},{"issue":"18","key":"10.1016\/j.thromres.2020.05.037_bb0125","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","article-title":"The post-thrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies a scientific statement from the American Heart Association","volume":"130","author":"Kahn","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.05.037_bb0130","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jvs.2008.09.014","article-title":"American Venous Forum. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document","volume":"49","author":"Eklof","year":"2009","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.thromres.2020.05.037_bb0135","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.05.037_bb0140","doi-asserted-by":"crossref","first-page":"D32","DOI":"10.1093\/eurheartj\/suv034","article-title":"Venous thromboembolism prevention and treatment: expanding the rivaroxaban knowledge base with real-life data","volume":"17","author":"Beyer-Westendorf","year":"2015","journal-title":"Eur. Heart J. Supp."},{"key":"10.1016\/j.thromres.2020.05.037_bb0145","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.114.009107","article-title":"30-year mortality after venous thromboembolism: a population-based cohort study","volume":"130","author":"S\u00f8gaard","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.05.037_bb0150","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S2352-3026(15)00257-4","article-title":"Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study","volume":"3","author":"Ageno","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2020.05.037_bb0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2019.02.010","article-title":"XALIA-LEA: an observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America (Open Access)","volume":"176","author":"Kreutz","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.05.037_bb0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.amjmed.2011.12.004","article-title":"Venous thromboembolism in patients with diabetes mellitus","volume":"125","author":"Piazza","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2020.05.037_bb0165","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00125-005-1715-5","article-title":"The risk of venous thromboembolism is markedly elevated in patients with diabetes","volume":"48","author":"Petrauskiene","year":"2005","journal-title":"Diabetologia."},{"key":"10.1016\/j.thromres.2020.05.037_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002698","article-title":"Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study","volume":"3","author":"Schmidt","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.thromres.2020.05.037_bb0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2014.11.003","article-title":"Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis","volume":"135","author":"Bai","year":"2015","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2020.05.037_bb0180","first-page":"178","article-title":"Diabetes and cardiovascular disease: from new mechanisms to new therapies","volume":"128","author":"Gajos","year":"2018","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2020.05.037_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-9560-12-21","article-title":"Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants","volume":"12","author":"Geldhof","year":"2014","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2020.05.037_bb0190","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/archinte.164.20.2260","article-title":"Venous thromboembolism according to age: the impact of an aging population","volume":"164","author":"Stein","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2020.05.037_bb0195","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1538-7836.2010.03852.x","article-title":"Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry","volume":"8","author":"Nieto","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.05.037_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thromres.2011.09.013","article-title":"Use of anticoagulants in elderly patients","volume":"129","author":"Bauersachs","year":"2012","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2020.05.037_bb0205","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s11239-019-01966-y","article-title":"Venous thromboembolism 2011\u20132018 in Stockholm: a demographic study","volume":"48","author":"W\u00e4ndell","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"issue":"3","key":"10.1016\/j.thromres.2020.05.037_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2217\/fca-2019-0003","article-title":"The changing face of venous thromboembolism management in England","volume":"15","author":"Ramagopalan","year":"2019","journal-title":"Futur. Cardiol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820302097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820302097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:42:24Z","timestamp":1758735744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820302097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"alternative-id":["S0049384820302097"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.05.037","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptance of a potential major bleeding among patients with venous thromboembolism on long-term oral anticoagulation: the knowledge of the disease and therapy matters","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}